Abstract

Post stroke depression (PSD), which has been negatively correlated with increased stroke mortality and risk for recurrent stroke, affects nearly 30% of all stroke survivors and is often underdiagnosed and under treated. Evidence-based screening for PSD can lead to more accurate and early diagnosis and treatment for PSD.

Author Details

Tanya Trotter, MSN, APRN, PHCNS-BC, College of Nursing & Professional Disciplines, University of North Dakota, Grand Forks, North Dakota, USA; Dawn L. Denny, PhD, RN, ONC, Department of Nursing, College of Nursing & Professional Disciplines, University of North Dakota, Grand Forks, North Dakota, USA; Tracy Evanson, PhD, RN, PHNA-BC, Chair PhD Program in Nursing, College of Nursing and Professional Disciplines, University of North Dakota, Grand Forks, North Dakota, USA

Sigma Membership

Zeta Phi

Lead Author Affiliation

University of North Dakota, Grand Forks, North Dakota, USA

Type

Poster

Format Type

Text-based Document

Study Design/Type

N/A

Research Approach

N/A

Keywords:

Depression, Screening, Stroke

Conference Name

30th International Nursing Research Congress

Conference Host

Sigma Theta Tau International

Conference Location

Calgary, Alberta, Canada

Conference Year

2019

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Acquisition

Proxy-submission

Additional Files

download (142 kB)

Share

COinS
 

Evidence-based screening for post-stroke depression

Calgary, Alberta, Canada

Post stroke depression (PSD), which has been negatively correlated with increased stroke mortality and risk for recurrent stroke, affects nearly 30% of all stroke survivors and is often underdiagnosed and under treated. Evidence-based screening for PSD can lead to more accurate and early diagnosis and treatment for PSD.